| Tag | Content |
|---|
EnhancerAtlas ID | HS091-23594 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr19:18278510-18279280 |
Target genes | | Number: 37 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr19:18279144-18279163 | CTCTGCCCTCTTGTGGCAA | - | 6.52 | | RREB1 | MA0073.1 | chr19:18278769-18278789 | CCCCCACCCACCAACCTCCT | + | 6.75 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_09655 | chr19:18278529-18286880 | CD14 | | SE_10788 | chr19:18278723-18285557 | CD19_Primary | | SE_59429 | chr19:18271222-18286661 | Ly3 | | SE_60858 | chr19:18270817-18299850 | DHL6 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TAAAAAATAC AAAACCCGGC CAGGCATGGT GGTGGGCGCC TGTAATCCCA GTTACTCAAG 60
AGGCTGAGGC AGGAGAATCA CTTGAACGGG GAGGTGGAGT TTGCAGTGAG CAGAGATTAT 120
GCCAATGCAG TTCAGCCTGG GCAACAGAGC AACACTCTGC CTCAGAAAAG AAAAGAAAAA 180
AAAAATCGCC TGCTGTGCAA CCTACCATGC TGGGTGGCTG CGGCAGCCCT GTCCTGGGTT 240
CAAATCAGTT CAAATCCTGC CCCCACCCAC CAACCTCCTG AAGACCTCAG CCAGAGCCTC 300
CACCTCCCTC TTGGGCCTCA GGGAGGGCAC TGTCGCGTGC CAGGTGCTGT GCTAAGCACC 360
GTGCTCGTTA TGAGTTCATT TGGTCCTTTT CAAGCCCTTT GTAAAGTTTG CCCTTTACAG 420
CTGGGGAGAC TGAGGCACAG AACCGACAGC TGCCCTGTGC AAAGGCCAGC AGTGCTGGAG 480
TGAGCCTCTG GTGATGATGA GGGGCCTGGG CTGGCATCTT CTTGGGGGAC TCCATAGGCG 540
TTAACAGAAA CAAAAAAATG AGGGGTGTGG GTCAGGGTTC CCCAGCAGAG CTGGGCGAGC 600
CACCCTGGGT TCAGGCTGCC CTGAGCCAGG TCAGCTCTGC CCTCTTGTGG CAACCGGAGA 660
TATTGTACCC AGAACCCTCT CTCCTCAGCC AGACCCTGCC TCCCACCGGA CAGGCCCACT 720
GTGGGCTCAG CACCCACACA ACTGCACAAG CCCACCTTTC CTGTTCCTTC 770
|
